| ★ | Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy | | 55 | Estados Unidos | |
| 16 | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | 69 |
| 15 | Dietary Interventions to Slow Metabolic Deterioration in Menopausal Patients | | 175 | Estados Unidos | 70 |
| 4 | Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk | | 120 | Estados Unidos | 72 |
| 1 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 74 |
| 5 | Preparing Families for the Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS | | 109 | Estados Unidos | 72 |
| 6 | How a Nephrologist Diagnoses and Manages Chronic Kidney Disease | | 70 | Estados Unidos | 71 |
| 17 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 69 |
| 18 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 69 |
| 20 | Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD | | 60 | Estados Unidos | 69 |
| 11 | Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH | | 46 | Estados Unidos | 70 |
| 3 | Metreleptin-Neutralizing Antibodies Do Not Impact Treatment Outcomes in Generalized Lipodystrophy | | 40 | Estados Unidos | 73 |
| 8 | FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines | | 33 | Estados Unidos | 71 |
| 7 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 71 |
| 10 | Plaque Imaging and the TRANSFORM Trial in Myocardial Infarction | | 29 | Estados Unidos | 70 |
| 12 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 70 |
| 9 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 71 |
| 2 | Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP | | 17 | Estados Unidos | 73 |
| 13 | ACC Statement Examines Frailty, Cognitive Impairment, in Cardiovascular Disease | | 17 | Estados Unidos | 70 |
| 14 | What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD | | 12 | Estados Unidos | 70 |
| 19 | Improving Patient and Clinician Education on the Unified Airway | | 7 | Estados Unidos | 69 |